AJP - Heart Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 281: H48-H52, 2001;
0363-6135/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, S. P.
Right arrow Articles by Lefer, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, S. P.
Right arrow Articles by Lefer, D. J.
Vol. 281, Issue 1, H48-H52, July 2001

Cardioprotective actions of endogenous IL-10 are independent of iNOS

Steven P. Jones, Steven D. Trocha, and David J. Lefer

Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130

Myocardial ischemia-reperfusion (I/R) is a well-known stimulus for acute inflammatory responses that promote cell death and impair pump function. Interleukin-10 (IL-10) is an endogenous, potent anti-inflammatory cytokine. Recently, it has been proposed that IL-10 inhibits inducible nitric oxide synthase (iNOS) activity after myocardial I/R and consequently exerts cardioprotective effects. However, whether this actually occurs remains unclear. To test this hypothesis, we utilized iNOS-deficient (-/-), IL-10 -/-, and IL-10/iNOS -/- mice to examine the potential mechanism of IL-10-mediated cardioprotection after myocardial I/R. Wild-type, iNOS -/-, IL-10 -/-, and IL-10/iNOS -/- mice were subjected to in vivo myocardial ischemia (30 min) and reperfusion (24 h). Deficiency of iNOS alone did not significantly alter the extent of myocardial necrosis compared with wild-type mice. We found that deficiency of IL-10 resulted in a significantly (P < 0.05) larger infarct size than that in wild-type hearts. Interestingly, deficiency of both IL-10 and iNOS yielded significantly (P < 0.01) larger myocardial infarct sizes compared with wild-type animals. Histological examination of myocardial tissue samples revealed augmented neutrophil infiltration into the I/R myocardium of IL-10 -/- and IL-10/iNOS -/- mice compared with hearts of wild-type mice. These results demonstrate that 1) deficiency of endogenous IL-10 exacerbates myocardial injury after I/R; 2) the cardioprotective effects of IL-10 are not dependent on the presence or absence of iNOS; and 3) deficiency of IL-10 enhances the infiltration of neutrophils into the myocardium after I/R.

cytokines; nitric oxide; ischemia; myocardial injury; mouse


This article has been cited by other articles:


Home page
 Int ImmunolHome page
D. Frenkel, A. S. Pachori, L. Zhang, A. Dembinsky-Vaknin, D. Farfara, S. Petrovic-Stojkovic, V. J. Dzau, and H. L. Weiner
Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury
Int. Immunol., July 1, 2009; 21(7): 817 - 829.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
P. Zymek, D.-Y. Nah, M. Bujak, G. Ren, A. Koerting, T. Leucker, P. Huebener, G. Taffet, M. Entman, and N. G. Frangogiannis
Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling
Cardiovasc Res, May 1, 2007; 74(2): 313 - 322.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X. Zhao, Y.-R. Chen, G. He, A. Zhang, L. J. Druhan, A. R. Strauch, and J. L. Zweier
Endothelial nitric oxide synthase (NOS3) knockout decreases NOS2 induction, limiting hyperoxygenation and conferring protection in the postischemic heart
Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1541 - H1550.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. M Smith, S. Lecour, and M. N Sack
Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program
Cardiovasc Res, August 15, 2002; 55(3): 474 - 482.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. J. Lee and Y. K. Song
Cooperative Interaction between Interleukin 10 and Galectin-3 against Liver Ischemia-Reperfusion Injury
Clin. Cancer Res., January 1, 2002; 8(1): 217 - 220.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
T. Matsumoto and L. Claesson-Welsh
VEGF Receptor Signal Transduction
Sci. Signal., December 11, 2001; 2001(112): re21 - re21.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
M. S. S. Chang, J. P. Tam, and E. Sanders-Bush
Dissecting Intracellular Signaling Pathways with Membrane-Permeable Peptides
Sci. Signal., August 29, 2000; 2000(47): pl1 - pl1.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
E. Gross, K. Hawkins, A. Pushkin, P. Sassani, R. Dukkipati, N. Abuladze, U. Hopfer, and I. Kurtz
Phosphorylation of Ser982 in the sodium bicarbonate cotransporter kNBC1 shifts the HCO3- : Na+ stoichiometry from 3 : 1 to 2 : 1 in murine proximal tubule cells
J. Physiol., November 21, 2001; (2001) 200101295.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online